TrialFrontiers in public health2024

Cost-effectiveness analysis of bevacizumab combined with lomustine in the treatment of progressive glioblastoma using a Markov model simulation analysis.

Zhaoyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.